AQST MT Newswires 2 days ago Aquestive Therapeutics Says US FDA Finds Deficiencies in Anaphylm Application; Shares Fall Pre-Bell
AQST GlobeNewswire 2 days ago Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business Update
AQST Simply Wall St. 5 days ago Breakeven On The Horizon For Aquestive Therapeutics, Inc. (NASDAQ:AQST) 📊 AI Sentiment Positive 6/10